Traders went risk off.

Altria stock is gaining momentum as strong cash flow, dividend growth, and next-gen nicotine products position MO for income ...

So, should you buy or sell Altria stock after the recent decline? Before addressing this, if you are looking for an upside ...

The maker of Marlboro cigarettes reports weaker-than-expected quarterly earnings.

MO and PM ramp up smoke-free growth, using pricing power and innovation to counter falling cigarette demand and reshape ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

However, here’s the counterpoint: who cares about revenue growth when margins are so robust? This is where Altria surprises.

Altria (MO) is rated strong sell due to deteriorating fundamentals and an overvalued stock price. MO's premium Marlboro ...

"2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our ...

More people are turning to oral tobacco products for their nicotine needs. Yet here, too, Altria is failing to keep pace with ...

Altria stock is outperforming the market this year and has a high dividend yield. Altria has several qualities that benefit its shareholders.

Altria has underperformed the S&P 500 in recent years. The stock remains a dividend powerhouse with a yield above 7%. More recently, however, the stock has struggled as cigarette sales in the U.S.